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Defective hepatitis B virus (HBV) genomes derived from packaging and reverse transcription of spliced RNA pregenomes
were reported to be associated with progression to chronic infection. Since only two types with similarly spliced regions
were characterized so far we reasoned that additional ‘‘spliced’’ genome variants may exist. Therefore, we isolated a large
number of defective HBV genomes from sera of seven chronic carriers by full-length PCR. Forty-eight were found to contain
deletions caused by splicing as identified by cloning, subgenomic PCR, and sequencing. In total, 11 types of spliced genomes
derived from excision of 10 different introns were present in various combinations in each serum. This diversity resulted
from alternative usage of five splice donor and four acceptor sites present in most but not all HBV genotypes. All spliced
genomes shared sequence elements essential for replication as well as for transcription of the pre-C and pregenome/C
mRNAs and the X mRNA. Moreover, all contained the coding regions for the X protein and for precore/core or precore/
core fusion proteins but lacked the pre-S/S gene promoters. These data demonstrate substantial and HBV genotype-
dependent diversity of spliced genomes from which a variety of aberrant precore/core fusion proteins and normal X protein
but no functional envelope and P proteins could be expressed. These genomes and the encoded proteins may play a role
in the viral life cycle, persistence, and pathogenesis. q 1997 Academic Press
INTRODUCTION spliced RNAs) was identified in HBV DNA-transfected
cell lines, in HBV-transgenic mice, and in HBV-infected
Hepatitis B virus (HBV) infection causes a variety of
liver (Chen et al., 1989; Su et al., 1989a,b; Suzuki et al.,
liver diseases in humans. The clinical manifestations
1989, 1990; Choo et al., 1991; Kajino et al., 1991; Wu et
range from acute, fulminant, to chronic hepatitis; liver
al., 1991). The simultaneous synthesis of spliced andcirrhosis; and hepatocellular carcinoma. Most HBV ge-
unspliced HBV transcripts is reminiscent of the situationnomes in virions consist of a small partially double-
in HIV. Furthermore, HBV RNAs have a posttranscrip-stranded circular DNA which is converted into covalently
tional regulatory element (PRE) (Fig. 1) (Huang and Liang,closed circular (ccc) molecules in nuclei upon infection
1993; Huang and Yen, 1994, 1995), which seems to beof cells. The ccc HBV DNA serves as template for synthe-
functionally similar to a HIV RNA sequence element, des-sis of a set of viral transcripts, namely a 3.5-kb pre-C
ignated rev response element (Emerman et al., 1989;mRNA for translation of precore/HBe protein, a 3.5-kb
Hadzopoulou-Cladaras et al., 1989; Malim et al., 1989).pregenome/C mRNA coding for nucleocapsid and P pro-
In HIV, and possibly also in HBV, the elements posttran-tein, 2.4- and 2.1-kb pre-S/S mRNAs coding for surface
scriptionally regulate the ratio of spliced to nonsplicedproteins (HBs, pre-S1, and pre-S2 proteins), and a 0.9-
mRNAs. It is therefore well conceivable that splicedkb mRNA presumably coding for the X protein. All these
RNAs of HBV play a role in the life cycle of the virus.transcripts are unspliced, have different 5*-ends, and
From the two major types of spliced HBV RNAs knownshare the same 3*-end located at the unique polyadenyl-
so far, a single intron or two introns are removed (exonation/processing site of the HBV genome. Only the prege-
boundaries at positions 2447/489 and 2067/2350/ 2447/nomic RNA which contains a functional encapsidation
282, respectively; see Fig. 1) (Chen et al., 1989; Su et al.,signal at its 5*-end is encapsidated into core particles
1989a; Suzuki et al., 1989; Choo et al., 1991; Wu et al.,and reverse transcribed into progeny HBV DNA (for a
1991). In addition, in two minor spliced transcripts therecent review see Ganem, 1996).
regions between positions 2985 and 489 and positionsIn addition to these unspliced transcripts, a variable
2471 and 489 are removed (Fig. 1) (Suzuki et al., 1990).fraction of spliced 3.5-kb pre-C and pregenome/C
From these four spliced pregenomic RNAs only twomRNAs (up to more than 50% of the corresponding un-
(2447/489 and 2471/489) were detected in the form of
reverse-transcribed DNA in virions (Terre et al., 1991).1 To whom reprint requests should be addressed. Fax: (0049) 40
48051 221. Thus, the number of functional splice sites could be lim-
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genomes exist and whether or not they share common
features with those variants proposed to play a role in
viral persistence and pathogenicity. Therefore, we iso-
lated and characterized a large number of such genomes
from serum of seven chronically infected patients. Here,
we demonstrate that the types of defective genomes de-
rived from spliced pregenomic RNA are much greater
than known so far and that most of them could only
express X protein and aberrant core fusion proteins.
MATERIALS AND METHODS
Isolation of DNA from serum
Sera were from seven highly viremic patients with hep-
atitis B surface antigen-positive chronic hepatitis. From
each serum sample, 300 ml was incubated at 657C for 4
h in 20 mM Tris–HCl (pH 8.0), 10 mM EDTA, 0.1% SDS,
and 0.8 mg/ml proteinase K. The DNA was then extracted
with phenol and subsequently with chloroform and pre-
cipitated with ethanol using 20 mg tRNA as carrier. The
pellet was dissolved in 20 ml H2O.FIG. 1. HBV genome structure and spliced as well as unspliced
pregenomic transcripts. Spliced regions (dashed lines), exon bound-
Amplification and cloning of completearies, and primers used for full-length and subgenomic PCRs are indi-
virion-encapsidated HBV genomescated. PRE, posttranscriptional regulatory element; (A)n, poly(A) tail.
Serum HBV DNA was amplified as described pre-
viously (Gu¨nther et al., 1995) by PCR in 50 ml bufferited and only a subfraction of spliced pregenomic RNAs
containing 50 mM Tris – HCl (pH 8.3), 50 mM KCl, 1.5may be encapsidated and reverse transcribed. Alterna-
mM MgCl2 , 200 mM dNTP, 0.01% gelatin, 5 U Taq DNAtively, there may be many more functional splice sites
polymerase (Boehringer Mannheim, Germany), and 1which have not been detected so far.
mM primer P1 and P2 (P1, CCGGAAAGCTTGAGCTCT-Splicing of the pregenomic RNA is not unique for HBV
TCTTTTTCACCTCTGCCTAATCA; P2, CCGGAAAGC-but was also observed for the related woodchuck and
TTGAGCTCTTCAAAAAGTTGCATGGTGCTGG; HBV ho-duck (DHBV) hepatitis viruses (Hantz et al., 1992; Ogston
mologous sequences span nucleotides 1821 – 1841 andand Razman, 1992; Obert et al., 1996). Moreover, a
1823 – 1806, respectively; see Fig. 1 for position on thespliced version of the DHBV pregenomic RNA was shown
HBV genome; SstI sites used for cloning are under-to be essential for productive infection of ducks but dis-
lined). A 45-ml reaction premix was heated to 807C andpensable for virus replication when DHBV DNA was intro-
5 ml enzyme was then added. The amplification wasduced into hepatoma cell lines by transfection (Obert et
performed for 20 to 30 cycles, depending on the amountal., 1996). Similarly, the major types of spliced pregeno-
of template DNA, at 947C for 40 s, 607C for 1 min, andmic HBV RNAs are dispensable for virus replication when
727C for 4 min with an increment of 5 s per cycle in atested by transfection of cells with HBV DNA (Su et al.,
Perkin – Elmer thermocycler (48 wells). The PCR prod-1989a; Wu et al., 1991), but a function in vivo is not ex-
ucts were purified by phenol/chloroform (1/1) extractioncluded. In fact, it was suggested that defective genomes
and digested with SstI for at least 6 h. The cleaved DNAderived from the major singly spliced RNA (2447/489)
was separated on an agarose gel; fragments betweenplay a role in virus persistence because they were found
1.0 and 3.0 kb were recovered from the gel and clonedpredominantly in sera of patients with chronic infection
into pUC19.and much less frequently in those with an acute self-
limited course (Rosmorduc et al., 1995). Moreover, these Analysis of cloned HBV DNA by PCR and sequencing
genomes were shown to express much higher levels of
core and HBe proteins and of X gene transcripts than a The cloned HBV genomes were PCR amplified as de-
scribed above using 1 ml of bacterial glycerol stock cul-wild-type genome in transfection experiments, which
was speculated to be eventually important for immune ture and primers P1/P2. The resulting PCR products were
diluted 1:50 and 1 ml thereof was used as template forrecognition of the virus, viral persistence, and pathoge-
nicity (Rosmorduc et al., 1995). In this report we ad- amplification of subgenomic fragments in a 25-ml assay
with 0.1 mM primer combinations P1/P3 (P3: 2400–2381,dressed the question whether additional ‘‘spliced’’ HBV
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as the ratio between the 3.2-kb and the shorter PCR
products differed between the samples. Thus, each se-
rum sample seems to contain a characteristic set and
amount of short genomes. The short genomes always
constituted only a small fraction of the virus population
as evident from the lower intensity of the corresponding
bands and their more efficient amplification compared to
wild-type genomes. The latter was experimentally dem-
onstrated by amplification of a mixture of HBV DNAs 1.2
and 3.2 kb in length. The 1.2-kb HBV genomes were
FIG. 2. Size analysis of HBV genomes present in serum from seven amplified 10 times more efficiently than the 3.2-kb ge-
patients with chronic hepatitis B. HBV genomes were amplified in their nomes in a 30-cycle PCR with Taq polymerase (data not
entire length with primers P1/P2, separated in an agarose gel, and
shown). Therefore, even in sample b, which showed astained by ethidium bromide. The same pattern and relative amounts
1:1 ratio of full-length to short PCR fragments (Fig. 2), theof short genomes were found when the PCR was repeated with the
same samples (not shown). latter represent only a minor HBV genome subpopulation.
Cloning and PCR analysis of defective HBV genomes
CTTCGTCTGCGAGGCGAGGG), P4/P5 (P4: 2357–2380, For the analysis of the structure of the short HBV ge-
GGCAGGTCCCCTAGAAGAAGAACT; P5: 738–716, ATA- nomes, the amplified DNAs in the 1.0- to 3.0-kb length
ACTGAAAGCCAAACAGTGGG), and P6/P2 (P6: 634–656, range were recovered from the gel and cloned into vector
ATTCCTATGGGAGTGGGCCTCAG). The positions of the pUC19. Recombinants were obtained from all serum
primers are indicated in Fig. 1. The plasmid DNA of 34 samples and 55 plasmids were randomly chosen for a
representative clones was prepared and the HBV DNA further structural analysis. The approximate sizes and
insert was sequenced with vector-specific reverse and locations of deletions were first roughly mapped by three
forward primers and primer P4 using the SequiTherm overlapping subgenomic PCRs covering the whole ge-
Long-Read Cycle Sequencing Kit (Epicentre Technolo- nome and agarose gel analysis of the PCR fragments.
gies, Madison, WI) and an automated sequencer (LI- The primers chosen for this screening hybridized outside
COR, Lincoln, NE). of the intron sequences of the previously described sin-
gly and doubly spliced pregenomic RNAs (Fig. 1) be-
RESULTS cause we expected that a large fraction of molecules is
derived from spliced pregenomic RNA. This subgenomicAmplification of full-length HBV genomes from sera
PCR screen revealed various large deletions between
nucleotide positions 2357 and 738 in HBV genomes ofHBV DNA was isolated from sera of seven chronically
HBV-infected patients and amplified by PCR. In order to most of the plasmids (for representative examples see
Fig. 3), in some cases with additional adjacent deletionsobtain the entire length of the HBV genomes, primers
annealing at the very 3*- and 5*-ends of the HBV DNA in the C gene. The PCR analysis of individual genomes
from sample e, for example, even revealed five differentminus strand were used as described previously (Fig. 1)
(Gu¨nther et al., 1995). After separation of the PCR prod- types of deletions located between positions 2357 and
738 (Fig. 3, patient e, lanes 1 to 5). Deletions identical inucts in an ethidium bromide-stained agarose gel, a major
band corresponding to HBV genomes of 3.2-kb wild-type length in some genomes from one as well as from differ-
ent patients were also found (Fig. 3, patient d, lanes 1–length was visible in all samples (Fig. 2). In addition,
DNA with faster electrophoretic mobility corresponding 5, 7, and 9; patient e, lanes 1, 6, and 7). In a few cases,
no DNA fragments were amplified with the primers used,to molecules 1.5 to 3.2 kb in length was seen in all but
one sample, suggesting the presence of HBV genomes indicating deletions or mutations of the primer binding
sites in these genomes as experimentally confirmed be-containing large deletions (Fig. 2). Such genomes shorter
than full-length HBV were not observed after amplifica- low. In conclusion, the PCR analysis revealed the pres-
ence of one or more large internal deletions betweention of cloned wild-type HBV DNA (data not shown), indi-
cating that they occur in vivo and are not artificially cre- the 5*-end of the C gene and the 3*-end of the S gene
and that the population of defective genomes can beated by PCR. In samples a, b, and f the HBV ‘‘deletion’’
variants showed up as rather distinct bands, indicating highly heterogeneous in the serum of an individual.
dominant size classes of defective genomes (Fig. 2). In
Detailed structural analysis of defective HBVcontrast, a diffuse banding pattern was observed in sam-
genomesples d, e, and g, suggesting the presence of a much
more heterogeneous population of such genomes. Fur- The precise structures of the defective genomes were
determined by sequencing. To avoid redundant sequenc-thermore, the length of the short PCR products as well
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FIG. 3. Size analysis of deletions in cloned defective HBV genomes derived from patients d and e. Subgenomic fragments of nine cloned defective
genomes from each patient were amplified using primer combination P4/P5 spanning nucleotides 2357 to 738 (Fig. 1) and were separated in an
agarose gel and stained by ethidium bromide. WT, cloned wild-type HBV DNA (Galibert et al., 1979) was used as a template for PCR. The splice
donor and acceptor sites which delimit the deletions are indicated. The ‘‘splice’’ types of those cloned genomes whose sequences have been
determined (see Fig. 5) are indicated below the lanes.
ing of identical types of genomes, the defective genomes parts of the P and pre-S/S proteins and containing the
complete pre-S1 (region 1) and pre-S2/S (region 2) pro-from each serum sample were first classified according
to position and length of the deletions by subgenomic moters (Fig. 5, bottom).
The structures of the defective genomes indicate thatPCR analysis as described above. One or two genomes
representative of each genome class from each serum 10 different intronic sequences are removed from the
corresponding RNA pregenomes. The diversity in struc-were sequenced completely (in total 34 of the 55 cloned
genomes). In 27 of the 34 sequenced genomes, repre- ture is caused by alternative usage of five different splice
donor and four splice acceptor sites (Fig. 4). Anothersentative of 48 of the 55 cloned defective genomes,
splice donor/acceptor site-specific sequences were reason is the removal of more than one of these introns
as evident in genomes 2, 4, 7, and 10, with two intronsidentified at the deletion boundaries, indicating that the
deleted sequences correspond to introns removed from removed, and in genome 8, lacking three intronic se-
quences (Fig. 5). The number and types of genomes iden-pregenomic RNA (Fig. 4). In total, 11 different types of
defective genomes derived from spliced pregenomic tified in our study indicate that the various splicing sites
differ also quantitatively in their function. The most fre-RNA were found (Fig. 5). Although these 11 types differ
drastically in structure, they share some common fea- quently used splice donor site was at position 2447 (in
83% of the spliced genomes), approximately one-third astures. In particular, all defective genomes share se-
quences from nucleotide position 489 to position 2067 frequent was that at position 2067, and the remaining
three at positions 2087, 2471, and 2985 were rarely func-(Fig. 5, bottom). This region contains all known signals
required for conventional replication (DR1 and DR2), syn- tional (Fig. 4). A similar analysis for the four acceptor
sites revealed most frequent splicing at position 489 (inthesis and processing of pregenomic/C-mRNA, pre-C
mRNA, and X mRNA (C and X gene promoter, enhancer I 79% of the spliced genomes). Acceptor sites at positions
282 and 2350 were involved in every fifth spliced genomeand II, polyadenylation/processing site), and pregenomic
RNA encapsidation (Fig. 5, bottom). The presence of the and splicing at position 2902 was 10 times less frequent
than at the most prevalent one (Fig. 4).RNA encapsidation signal and of the direct repeat se-
quences is consistent with the isolation of the defective In view of the quantitative differences in splice site
usage we wondered whether this depends on the degreeHBV genomes from serum-derived viral particles. Fur-
thermore, common to all genomes is the presence of the of homology of the HBV splice sites with the splice con-
sensus sequences or on genotype-specific sequencecomplete X protein coding region and the complete C
ORF or truncated versions thereof fused to other ORFs variation within these sites. This analysis revealed a simi-
lar degree of homology of the different HBV splice sites(Fig. 5). All genomes lack sequences in two regions (posi-
tions 2471 to 2902 and 2985 to 282), both coding for with the consensus sequences (Fig. 4). From the minor
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signals (Fig. 4). With one exception, all of these changes
are consistent with the splice consensus sequences, but
an influence of some of them on recognition by the splic-
ing apparatus is conceivable. The exception concerns
the splice donor site at position 2087. In HBV genotypes
A, D, and E there is a G residue instead of a T or C
in the invariable /2 position of the splice consensus
sequence which should inactivate this splice donor site
in these genomes. This is consistent with our observation
that spliced genomes generated via this splice site did
not belong to any of these genotypes but were exclu-
sively of genotype B.
DISCUSSION
In this study we provide evidence for the existence of
a large variety of defective HBV genomes derived from
spliced pregenomic RNA (HBV splice variants). Se-
quence analysis revealed four donor and five acceptor
splice sites used in different combinations and frequen-
cies depending in part on the HBV genotype. The splice
variants represented a minor population compared to
wild-type genomes, and their relative amounts and types
seem to differ from patient to patient. Common to all the
splice variants was the presence of the X gene and all
known regulatory sequences required for pre-C and pre-
genome/C mRNA synthesis and genome replication. In
contrast, all lacked the pre-S/S gene promoter regions
and contiguous coding regions for the envelope and P
proteins. The C gene was fused in most genomes with
other reading frames. These findings indicate a more
complex splicing of pregenomic HBV RNA than known
so far and may imply a role of the corresponding splice
variant genomes and expressed proteins in the viral life
FIG. 4. Putative 5*- and 3*-splice signals in HBV used to generate cycle, viral persistence, and pathogenesis.
the spliced genomes shown in Fig. 5 and their conservation in different One interesting finding of our study is the high degree
HBV genotypes. The sequences at the deletion junctions were aligned
of inter- as well as intrapatient structural variability ofto the consensus sequences for the 5*-splice site (MAG/GTRAGT; a C
defective spliced genomes which only became obviousnucleotide shown in parentheses at position /2 is compatible with
function but occurs rarely), the 3*-splice site (YAG/G), and the branch because of amplification of entire HBV genomes. The
site (YNYYRAY) (Mount, 1982; Zeitlin and Efstratiadis, 1984; Jackson, data obtained extend previous investigations based on
1991). Invariable nucleotide positions are boxed. Only one possible subgenomic PCRs which led to the identification of ‘‘sin-
branch site which most perfectly matches the consensus is indicated.
gly spliced’’ genomes of types 1 and 6 in serum butPyrimidine residues forming the polypyrimidine tract located between
failed to detect other spliced genomes (Terre et al., 1991;the putative branch site and the 3*-splice site are underlined. HBV
genotype-specific nucleotide changes in splice signals are indicated Rosmorduc et al., 1995). In agreement with these reports,
below the sequences and the corresponding genotype is given in pa- we also found splice variants in different relative
rentheses. Genotype-specific AGs are also indicated (encircled) be- amounts in individual samples and only as minor popula-
cause they may serve as alternative 3*-splice sites or inhibit splicing
tions consisting predominantly of defective genomes ofas reported in other systems (Smith et al., 1989). The frequency of use
type 1. The latter accounted for 50% of all splice variantof a specific splice site was calculated by dividing the number of
genomes spliced at this site by the total number of genomes analyzed genomes analyzed and were present in sera from five of
(n  48). seven patients. All other splice variant genomes were
much less prevalent and this may be one reason why
they have not been detected before.differences in homology no association with the fre-
Previously described splice sites and the HBV geno-quency of splicing at a specific site can be inferred.
type-specific splice donor site 2087 identified in our studyInterestingly, a sequence data bank search uncovered
genotype-specific sequence variation within the splice sum up to five donor and four acceptor sites used for
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splicing of pregenomic RNA. The donor sites 2067 and highly conserved. A notable exception is a genotype-
specific T to G mutation in position /2 of the splice2447 and the acceptor sites 2350, 282, and 489 are fre-
quently involved in pregenomic RNA splicing (Chen et donor site 2087 which is not compatible with splice site
recognition (Mount, 1982; Jackson, 1991). Mutations out-al., 1989; Su et al., 1989a; Suzuki et al., 1989; Choo et
al., 1991; Wu et al., 1991), whereas splicing was rarely side of splice site recognition sequences, such as the
deletions in the C gene of some of the genomes studieddetected at the donor site 2985 and occurred only after
inactivation of the 2447 donor site at a cryptic site at or the HBV genotype-specific insertions close to the 2350
and 2902 acceptor sites, may also influence splice siteposition 2471 (Suzuki et al., 1990). Based on the deletion
of nucleotides 2448 to 2901 in chromosomally integrated selection by altering the RNA structure. Provided splicing
in HBV is functionally important, the presumed HBV geno-HBV DNA from the human hepatoma cell line PLC/PRF/
5 (Ziemer et al., 1985), the existence of a functional donor type-specific variation in splicing and the complex prege-
nomic RNA splicing patterns observed may imply thatsite at position 2902 was so far only suggested (Terre et
al., 1991). Our study demonstrates the function of the some splice sites are functionally redundant, e.g., they
could have the same effects. In this case, knockout ofsplice site at position 2902 and suggests moreover that
the HBV DNA integrated in these cells arose from infec- specific sites would be tolerable. This conclusion does
not exclude an essential function of a subset of splicetion with a corresponding splice variant. Thus, splice
variant genomes may also play a role in hepatocarcino- sites for some aspects of infection. Consistent with the
latter speculation is the use of the splice acceptor sitesgenesis. Strikingly, most of the splice sites which gave
rise to the defective genomes described here were pre- 282 and 489 in all genomes. These two sites may be
functionally important for the HBV life cycle.viously identified on the RNA level, but in only 3 of the 11
splicing patterns, namely types 1, 6, and 10. The splicing An intriguing observation is the apparent absence of
splice sites downstream of position 489 and upstreampatterns 1, 10, and 6 correspond to the most prevalent
singly and doubly spliced pregenomic RNAs (Chen et al., of position 2067. This may be due to the lack of such
splicing sites, to too low sensitivity of our assays, or to1989; Su et al., 1989a; Suzuki et al., 1989; Choo et al.,
1991; Wu et al., 1991) and to the rare variant in which the fact that we have analyzed only genomes greater
than 1.0 kb. Since very small HBV genomes could besplicing occurs at the cryptic site at position 2471, re-
spectively (see Fig. 1) (Suzuki et al., 1990). generated if splicing started in the C gene and extended
up to the X gene region, we analyzed in an independentIt is not clear why the efficiency and type of splicing
differs from patient to patient. One possible reason could study amplified HBV DNA fragments smaller than 1.0 kb
by cloning and sequencing of PCR fragments. In thesebe sequence variations which create, destroy, or modu-
late the function of splice signal sequences. Four se- experiments, defective genomes with extremely large de-
letions were found but none was generated by splicingquence elements on the RNA are important in the splic-
ing process: the 5*-splice site (consensus: MAG/ (G.S., unpublished observation). Therefore, we currently
believe that there are no splice sites downstream of posi-GTRAGT), the 3*-splice site (consensus: YAG/G), and the
branch site (consensus: YNYYRAY) 20–50 nucleotides tion 486 and upstream of 2067.
Taking our and previously published data (Chen et al.,upstream thereof, as well as a polypyrimidine tract be-
tween the 3*-splice and the branch site (Mount, 1982; 1989; Su et al., 1989a; Suzuki et al., 1989, 1990; Choo et
al., 1991; Terre et al., 1991; Wu et al., 1991) together it isZeitlin and Efstratiadis, 1984). All HBV splice donor and
acceptor sites identified in our study are in close agree- evident that both the pre-C and the C mRNAs can be
extensively spliced. As a consequence a large numberment with these consensus sequences. However, we
noted that they differ in some HBV genotypes which may of aberrant precore and core fusion proteins are presum-
ably expressed from these RNAs. Some of these proteinshave quantitative and qualitative effects on the splicing
of the genotype-specific RNA pregenomes. This specula- could negatively interfere with the viral assembly process
as shown for artificial core fusion proteins (Scaglioni ettion needs to be experimentally examined because the
sequences involved in splice site recognition are not al., 1994, 1996; von Weizsa¨cker et al., 1996). Such defec-
FIG. 5. Types of defective HBV genomes classified according to the splice pattern. Deletions generated by splicing are indicated by thin lines,
whereas in-frame deletions in the C gene which do not result from splicing are shown as a dashed line. Nucleotide positions at the exon boundary
and the lengths of deletions calculated on the basis of the genotype D wild-type genome (Galibert et al., 1979) with numbering starting in the
middle of the EcoRI site are given. Note. Positions or lengths are different in other genotypes due to genotype-specific insertions. Conventional
and novel open reading frames (ORFs) present in each type of genome are shown and capital letters indicate the origin of each part of these ORFs
with respect to the conventional HBV ORFs (C, P, S, and X as shown on top), whereas nonconventional ORF parts are filled. The nonconventional
3*-ORF parts in types 1, 4, 6, 7, 9, and 11 terminate in a genotype-specific manner at heterogeneous positions as indicated by multiple arrows at
the end of these frames. HBV sequences and regulatory DNA and RNA elements shared by (black boxes) and lacking in all (interruptions) spliced
genomes are schematically shown at the bottom line. DR1 and DR2, direct repeat sequences; S1p and S2p, S gene promoters; Xp, X gene promoter;
EnI, enhancer I; Cp/EnII, C gene promoter/enhancer II; pA, processing/polyadenylation signal; e, RNA encapsidation signal.
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tive proteins are predictably abundant in the cell relative can synthesize ccc DNA and a corresponding prege-
nome-like RNA, they could presumably replicate indefi-to the nondefective proteins since a large fraction and
sometimes even most of the pre-C and C mRNAs are nitely when supplemented in trans with the essential
virus proteins from wild-type virus. This may contributespliced in infected liver and in HBV DNA-transfected cells
(Chen et al., 1989; Su et al., 1989a,b; Suzuki et al., 1989, to their accumulation and, consequently, to enhanced
expression of X protein and of aberrant core proteins.1990; Kajino et al., 1991; Wu et al., 1991). Their predicted
abundance makes them ideal candidates for acting as The data presented and the clones obtained in our study
provide the basis to prove or disprove these predictionsinhibitors of virus multiplication similarly to defective in-
terfering particles (Holland, 1990). A carboxy-terminal P as well as the possible role of the splice variants in the
viral life cycle, persistence, and pathogenesis.(fusion) protein with RNase H activity could eventually
be translated from all spliced pregenomic/C mRNAs pro-
vided that translational scanning occurs as shown for ACKNOWLEDGMENTS
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